glp 1 and migraines GLP-1 Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity chronic migraine. Participants reported an average Semaglutide and Migraines: Patient Reports
Description
See how RYBELSUS performed in the PIONEER 3 Trial
Clinical trials of FDA-approved tirzepatide products have shown weight-related effects in some participants when used alongside diet and lifestyle changes
GLP-1 and similar hormone-activating medications can significantly reduce appetite, support weight loss and control blood sugar
The study demonstrates how data science can uncover meaningful public health trends and help inform safer medication use
